Abstract
Background Heart failure is a leading public health issue in China, with a steadily increasing burden. This study aims to assess the changing patterns of heart failure in China from 1990 to 2021, providing evidence for informed healthcare strategies.
Methods Data on prevalence, years lived with disability (YLDs), and their corresponding 95% uncertainty intervals (UI) were obtained from the Global Burden of Disease (GBD) Study 2021. The joinpoint regression model was used to identify both overall and localized trends of heart failure burden, and the age-period-cohort model served to analyze the contributions of age, period, and birth cohort separately. We further utilized the autoregressive integrated moving average (ARIMA) model to predict future trends of heart failure in the next 10 years.
Results In 2021, 13099727 (95% UI, 11320895 to 15376467) individuals lived with heart failure and this illness accounted for 1290810 (95% UI, 865894 to 1775731) YLDs in China. The burden of heart failure is more pronounced in males and the elderly, and ischemic heart disease has become the leading cause since 2002. The age-standardized rates of prevalence and YLDs increased at average annual percentage changes of 0.23% (95% CI, 0.20 to 0.26) and 0.25% (95% CI, 0.23 to 0.27) respectively. The curve of local drift showed a downward trend with age. Both the period and cohort rate ratios have increased significantly over the last 30 years. By 2031, the age-standardized rates of prevalence will decrease to 678.69 (95% CI, 640.75 to 716.63), while the age-standardized rates of YLDs will increase to 69.19 (95% CI, 66.95 to 71.43).
Conclusions The burden of heart failure in China remains concerning. The implementation of comprehensive strategies should be taken into consideration, including strengthening primary healthcare system, enhancing public awareness, and promoting cardiac rehabilitation.
What Is New?
This is the first study of the Global Burden of Disease (GBD) 2021 that comprehensively analyzes the burden of heart failure in China over the past 30 years.
What Are the Clinical Implications?
The burden of heart failure in China remains concerning.
Comprehensive strategies prioritizing primary healthcare system, public awareness, and cardiac rehabilitation could be effective to mitigate the burden of heart failure.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the National Key Research and Development Program of China (grant number: 2022YFC3500101).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
For the secondary analysis of the Global Burden of Disease studies, the Institutional Review Board of the University of Washington reviewed and approved a waiver of informed consent (https://www.healthdata.org/research-analysis/gbd).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Datasets analyzed for this study are publicly available at https://vizhub.healthdata.org/gbd-results/.
Non-standard Abbreviations and Acronyms
- AAPC
- Average Annual Percentage Changes
- ACF
- Autocorrelation Function
- AIC
- Akaike Information Criterion
- APC
- Annual Percentage Changes
- The APC model
- The age-period-cohort model
- ARIMA
- Autoregressive Integrated Moving Average
- ASR
- Age-Standardized Rate
- DALYs
- Disability-Adjusted Life-Years
- GBD
- Global Burden of Disease
- HAQ
- Healthcare Quality and Access
- HF
- Heart Failure
- MR-BRT
- Meta-Regression—Bayesian, Regularized, Trimmed
- UI
- Uncertainty Interval
- WHO
- World Health Organization
- YLDs
- Years Lived with Disability
- YLLs
- Years of Life Lost
